{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:50:47Z","timestamp":1793638247383,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03712-8","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:31:36Z","timestamp":1744371096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-biofilm and anti-quorum sensing activities of galloylquinic acid against clinical isolates of multidrug-resistant Pseudomonas aeruginosa in open wound infection: in vitro and in vivo efficacy studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Lamiaa A.","family":"Al-Maddboly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9920-1520","authenticated-orcid":false,"given":"Mohamed Abd","family":"El-Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo K.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman A.","family":"Hasby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-7137","authenticated-orcid":false,"given":"Ivan","family":"Kushkevych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"El-Morsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"4","key":"3712_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.idc.2020.08.002","volume":"34","author":"D van Duin","year":"2020","unstructured":"van Duin D, Paterson DL. Multidrug-resistant Bacteria in the community: an update. Infect Dis Clin North Am. 2020;34(4):709\u201322.","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"3712_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","volume":"15","author":"RM Donlan","year":"2002","unstructured":"Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167\u201393.","journal-title":"Clin Microbiol Rev"},{"issue":"2 Suppl","key":"3712_CR3","first-page":"59","volume":"16","author":"OM Oluwole","year":"2022","unstructured":"Oluwole OM. BIOFILM: FORMATION AND NATURAL PRODUCTS\u2019 APPROACH TO CONTROL - A REVIEW. Afr J Infect Dis. 2022;16(2 Suppl):59\u201371.","journal-title":"Afr J Infect Dis"},{"key":"3712_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","volume":"8","author":"D Sharma","year":"2019","unstructured":"Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8:76.","journal-title":"Antimicrob Resist Infect Control"},{"key":"3712_CR5","doi-asserted-by":"crossref","unstructured":"Vestby LK et al. Bacterial biofilm and its role in the pathogenesis of Disease. Antibiot (Basel), 2020. 9(2).","DOI":"10.3390\/antibiotics9020059"},{"key":"3712_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fmicb.2019.00913","volume":"10","author":"O Ciofu","year":"2019","unstructured":"Ciofu O, Tolker-Nielsen T. Tolerance and resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial agents-How P. Aeruginosa Can escape antibiotics. Front Microbiol. 2019;10:913.","journal-title":"Front Microbiol"},{"issue":"5","key":"3712_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/1040841X.2023.2282459","volume":"50","author":"G-J Jeong","year":"2024","unstructured":"Jeong G-J, et al. Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa. Crit Rev Microbiol. 2024;50(5):830\u201358.","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"3712_CR8","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00253-019-09618-0","volume":"103","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, et al. Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors. Appl Microbiol Biotechnol. 2019;103(8):3521\u201335.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"3712_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276\u2013301.","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"3712_CR10","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1128\/AAC.06486-11","volume":"56","author":"W Hengzhuang","year":"2012","unstructured":"Hengzhuang W, et al. In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother. 2012;56(5):2683\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"3712_CR11","doi-asserted-by":"crossref","unstructured":"Mishra R et al. Natural anti-biofilm agents: strategies to Control Biofilm-forming pathogens. Front Microbiol. 2020;11.","DOI":"10.3389\/fmicb.2020.566325"},{"issue":"2","key":"3712_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcf.2016.08.005","volume":"16","author":"L Fern\u00e1ndez-Barat","year":"2017","unstructured":"Fern\u00e1ndez-Barat L, et al. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment. J Cyst Fibros. 2017;16(2):222\u20139.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"3712_CR13","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s42770-024-01410-1","volume":"55","author":"BN Guedes","year":"2024","unstructured":"Guedes BN, et al. Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems. Brazilian J Microbiol. 2024;55(3):2753\u201366.","journal-title":"Brazilian J Microbiol"},{"issue":"1","key":"3712_CR14","first-page":"58","volume":"20","author":"AL Guimar\u00e3es","year":"2016","unstructured":"Guimar\u00e3es AL, et al. Antimicrobial activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) oils against Staphylococcus Aureus: importance in compounding for Wound Care. Int J Pharm Compd. 2016;20(1):58\u201362.","journal-title":"Int J Pharm Compd"},{"issue":"7","key":"3712_CR15","doi-asserted-by":"publisher","first-page":"Fso587","DOI":"10.2144\/fsoa-2020-0018","volume":"6","author":"JA Alves","year":"2020","unstructured":"Alves JA, et al. Investigation of Copaifera Genus as a new source of antimycobaterial agents. Future Sci OA. 2020;6(7):Fso587.","journal-title":"Future Sci OA"},{"key":"3712_CR16","doi-asserted-by":"publisher","first-page":"120497","DOI":"10.1016\/j.lfs.2022.120497","volume":"299","author":"MA Abd El-Salam","year":"2022","unstructured":"Abd El-Salam MA, et al. Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the notch signaling pathway modulation. Life Sci. 2022;299:120497.","journal-title":"Life Sci"},{"issue":"5","key":"3712_CR17","doi-asserted-by":"publisher","first-page":"e0272421","DOI":"10.1128\/spectrum.02724-21","volume":"10","author":"LA Al-Madboly","year":"2022","unstructured":"Al-Madboly LA, et al. Novel preclinical study of Galloylquinic Acid compounds from Copaifera lucens with potent antifungal activity against Vaginal Candidiasis Induced in a murine model via Multitarget modes of Action. Microbiol Spectr. 2022;10(5):e0272421.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"3712_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12934-024-02421-1","volume":"23","author":"LA Al-Madboly","year":"2024","unstructured":"Al-Madboly LA, et al. Characterization of GQA as a novel \u03b2-lactamase inhibitor of CTX-M-15 and KPC-2 enzymes. Microb Cell Fact. 2024;23(1):221.","journal-title":"Microb Cell Fact"},{"key":"3712_CR19","doi-asserted-by":"publisher","unstructured":"El-Salam MA, Furtado N, Haskic Z, Lieske J, Bastos J. Antiurolithic activity and biotransformation of galloylquinic acids by Aspergillus alliaceus ATCC10060, Aspergillus brasiliensis ATCC 16404, and Cunninghamella elegans ATCC 10028b. Biocatal Agric Biotechnol. 2019;18:101012. https:\/\/doi.org\/10.1016\/j.bcab.2019.01.050","DOI":"10.1016\/j.bcab.2019.01.050"},{"issue":"8","key":"3712_CR20","doi-asserted-by":"publisher","first-page":"e04761","DOI":"10.1016\/j.heliyon.2020.e04761","volume":"6","author":"AE El-Sisi","year":"2020","unstructured":"El-Sisi AE, et al. The potential beneficial effects of sildenafil and diosmin in experimentally-induced gastric ulcer in rats. Heliyon. 2020;6(8):e04761.","journal-title":"Heliyon"},{"key":"3712_CR21","doi-asserted-by":"publisher","first-page":"121085","DOI":"10.1016\/j.lfs.2022.121085","volume":"310","author":"AM Abo Kamer","year":"2022","unstructured":"Abo Kamer AM, et al. Characterization of newly isolated bacteriophage to control multi-drug resistant Pseudomonas aeruginosa colonizing incision wounds in a rat model: in vitro and in vivo approach. Life Sci. 2022;310:121085.","journal-title":"Life Sci"},{"issue":"1","key":"3712_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/fcp.12563","volume":"35","author":"NA El-Mahdy","year":"2021","unstructured":"El-Mahdy NA, et al. Targeting IL-10, ZO-1 gene expression and IL-6\/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis. Fundam Clin Pharmacol. 2021;35(1):143\u201355.","journal-title":"Fundam Clin Pharmacol"},{"key":"3712_CR23","doi-asserted-by":"crossref","unstructured":"Weinstein MP, Lewis JS 2. nd, The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial susceptibility testing: background, Organization, functions, and processes. J Clin Microbiol, 2020. 58(3).","DOI":"10.1128\/JCM.01864-19"},{"issue":"1","key":"3712_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13020-021-00481-8","volume":"16","author":"L Lu","year":"2021","unstructured":"Lu L, et al. Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa. Chin Med. 2021;16(1):72.","journal-title":"Chin Med"},{"issue":"1","key":"3712_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12934-022-01988-x","volume":"21","author":"AA Abdelaziz","year":"2022","unstructured":"Abdelaziz AA, et al. A purified and lyophilized Pseudomonas aeruginosa derived pyocyanin induces promising apoptotic and necrotic activities against MCF-7 human breast adenocarcinoma. Microb Cell Fact. 2022;21(1):262.","journal-title":"Microb Cell Fact"},{"issue":"2","key":"3712_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-7012(00)00122-6","volume":"40","author":"S Stepanovic","year":"2000","unstructured":"Stepanovic S, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175\u20139.","journal-title":"J Microbiol Methods"},{"issue":"1","key":"3712_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13104-020-4890-z","volume":"13","author":"E Kamali","year":"2020","unstructured":"Kamali E, et al. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes. 2020;13(1):27.","journal-title":"BMC Res Notes"},{"issue":"1","key":"3712_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41522-021-00208-5","volume":"7","author":"AC Duarte","year":"2021","unstructured":"Duarte AC, et al. Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms. NPJ Biofilms Microbiomes. 2021;7(1):39.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"3712_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jtcme.2017.05.008","volume":"8","author":"P Sankar Ganesh","year":"2018","unstructured":"Sankar Ganesh P, Ravishankar Rai V. Attenuation of quorum-sensing-dependent virulence factors and biofilm formation by medicinal plants against antibiotic resistant Pseudomonas aeruginosa. J Tradit Complement Med. 2018;8(1):170\u20137.","journal-title":"J Tradit Complement Med"},{"issue":"6","key":"3712_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","volume":"52","author":"T Tkhilaishvili","year":"2018","unstructured":"Tkhilaishvili T, et al. Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus. Int J Antimicrob Agents. 2018;52(6):842\u201353.","journal-title":"Int J Antimicrob Agents"},{"issue":"24","key":"3712_CR31","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.3390\/molecules27248935","volume":"27","author":"D Rachmawati","year":"2022","unstructured":"Rachmawati D, et al. In Vitro Assessment on Designing Novel antibiofilms of Pseudomonas aeruginosa using a Computational Approach. Molecules. 2022;27(24):8935.","journal-title":"Molecules"},{"issue":"10","key":"3712_CR32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1099\/jmm.0.000327","volume":"65","author":"S El-Shaer","year":"2016","unstructured":"El-Shaer S, et al. Control of quorum sensing and virulence factors of Pseudomonas aeruginosa using phenylalanine arginyl \u03b2-naphthylamide. J Med Microbiol. 2016;65(10):1194\u2013204.","journal-title":"J Med Microbiol"},{"issue":"9","key":"3712_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"HC Flemming","year":"2010","unstructured":"Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"3712_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biologicals.2019.10.003","volume":"63","author":"M Adnan","year":"2020","unstructured":"Adnan M, et al. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Biologicals. 2020;63:89\u201396.","journal-title":"Biologicals"},{"issue":"1","key":"3712_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s13104-019-4795-x","volume":"12","author":"W Deveaux","year":"2019","unstructured":"Deveaux W, Selvarajoo K. Searching for simple rules in Pseudomonas aeruginosa biofilm formation. BMC Res Notes. 2019;12(1):763.","journal-title":"BMC Res Notes"},{"issue":"2","key":"3712_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biotechadv.2012.10.004","volume":"31","author":"VC Kalia","year":"2013","unstructured":"Kalia VC. Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013;31(2):224\u201345.","journal-title":"Biotechnol Adv"},{"key":"3712_CR37","doi-asserted-by":"crossref","unstructured":"Pancu DF et al. Antibiotics: conventional therapy and natural compounds with antibacterial Activity-A Pharmaco-Toxicological screening. Antibiot (Basel), 2021. 10(4).","DOI":"10.3390\/antibiotics10040401"},{"key":"3712_CR38","doi-asserted-by":"publisher","first-page":"1352273","DOI":"10.3389\/fcimb.2024.1352273","volume":"14","author":"KE Grooters","year":"2024","unstructured":"Grooters KE, et al. Strategies for combating antibiotic resistance in bacterial biofilms. Front Cell Infect Microbiol. 2024;14:1352273.","journal-title":"Front Cell Infect Microbiol"},{"key":"3712_CR39","doi-asserted-by":"crossref","unstructured":"Sweet R et al. Comparison of Antibacterial Activity of Phytochemicals against Common Foodborne pathogens and potential for selection of resistance. Microorganisms, 2023. 11(10).","DOI":"10.3390\/microorganisms11102495"},{"key":"3712_CR40","doi-asserted-by":"publisher","first-page":"883839","DOI":"10.3389\/fcimb.2022.883839","volume":"12","author":"T Suganya","year":"2022","unstructured":"Suganya T, et al. Tackling multiple-drug-resistant Bacteria with conventional and complex phytochemicals. Front Cell Infect Microbiol. 2022;12:883839.","journal-title":"Front Cell Infect Microbiol"},{"key":"3712_CR41","doi-asserted-by":"crossref","unstructured":"da Trindade R, da Silva JK, Setzer WN. Copaifera of the neotropics: a review of the Phytochemistry and Pharmacology. Int J Mol Sci, 2018. 19(5).","DOI":"10.3390\/ijms19051511"},{"key":"3712_CR42","doi-asserted-by":"crossref","unstructured":"Tuon FF et al. Pathogenesis of the Pseudomonas aeruginosa Biofilm: a review. Pathogens, 2022. 11(3).","DOI":"10.3390\/pathogens11030300"},{"issue":"4","key":"3712_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1472-765X.2004.01591.x","volume":"39","author":"JH Ryu","year":"2004","unstructured":"Ryu JH, et al. Attachment and biofilm formation on stainless steel by Escherichia coli O157:H7 as affected by curli production. Lett Appl Microbiol. 2004;39(4):359\u201362.","journal-title":"Lett Appl Microbiol"},{"issue":"7","key":"3712_CR44","doi-asserted-by":"publisher","first-page":"e17657","DOI":"10.1016\/j.heliyon.2023.e17657","volume":"9","author":"EMF Lima","year":"2023","unstructured":"Lima EMF, Winans SC, Pinto UM. Quorum sensing interference by phenolic compounds - A matter of bacterial misunderstanding. Heliyon. 2023;9(7):e17657.","journal-title":"Heliyon"},{"issue":"1","key":"3712_CR45","doi-asserted-by":"publisher","first-page":"10618","DOI":"10.1038\/s41598-017-10997-5","volume":"7","author":"MA Hossain","year":"2017","unstructured":"Hossain MA, et al. Impact of phenolic compounds in the acyl homoserine lactone-mediated quorum sensing regulatory pathways. Sci Rep. 2017;7(1):10618.","journal-title":"Sci Rep"},{"issue":"5","key":"3712_CR46","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00253-018-8787-x","volume":"102","author":"FJ Reen","year":"2018","unstructured":"Reen FJ, et al. Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition. Appl Microbiol Biotechnol. 2018;102(5):2063\u201373.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3712_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1134\/S0026261719010132","volume":"88","author":"KS Inchagova","year":"2019","unstructured":"Inchagova KS, Duskaev GK, Deryabin DG. Quorum sensing inhibition in Chromobacterium violaceum by Amikacin Combination with activated charcoal or small plant-derived molecules (pyrogallol and coumarin). Microbiology. 2019;88(1):63\u201371.","journal-title":"Microbiology"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03712-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:16:32Z","timestamp":1745298992000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03712-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03712-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocol procedure followed the institutional animal care and use committee (IACUC) of laboratory animals and according to the guidelines of Animal Research: Reporting of In Vivo Experiments (ARRIVE). The protocol for animal infection was approved by the Animal Care and Use Ethics Committee of the Faculty of Pharmacy, Tanta University, Tanta, Egypt, # (TP \/ RE\/3\/23p-0012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}